Sanara MedTech Inc. (SMTI) exhibits 92.7% gross margins and 16.3% return on invested capital within Health Care (Industrial Specialties), balanced against a 29.5x enterprise multiple and 4.8% implied options volatility.
Sustained 92.7% gross profitability converts into 7.1% operating margin and 16.3% ROIC, outpacing sector cost of capital.
ROIC: 16.3% // GM: 92.7%YoY revenue trajectory of +19.0% paired with 0.71% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +19.0% // FCF YLD: 0.71%Altman Z-Score of 3.25 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.25 // F-SCORE: 7/9Trading at 8.1x trailing P/E (6.8x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 8.1x // EV/EBITDA: 29.5xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $32.92 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Industrial Specialties require continuous execution to defend 36.4% net margins.
NET MARGIN: 36.4% // D/E: 7.74x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for SMTI & activate live FRED threshold breach alerts.